Slide 1: 2Q Fiscal 2026 Webcast
2Q Fiscal 2026 Webcast May 21, 2026
Slide 2: Safe Harbor Statement
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as
Slide 3: Agenda
Agenda 2Q 2026 Webcast – May 21, 2026 2nd Quarter Highlights Enterprise Performance Sales & Earnings Performance 2026 Guidance Update Balance Sheet and Cash Flow Q&A Sundaram Nagarajan Dan Hopgood Lara Mahoney President & Executive Vice President & Vice President, 3 Chief Executive Offic
Slide 4: 2Q 2026 Highlights
Record Q2 sales of $741M, an 8% increase over prior year, up 7% organically Record Q2 sales in all segments Order entry momentum continues, backlog up 18% compared to prior year 2Q 2026 Record Q2 EBITDA of $235M, or 32% of sales Highlights Record Q2 adjusted EPS of $2.86, Strong sales and earnings p
Slide 5: Total Company – 2Q 2026
Total Company – 2Q 2026 2Q 2026 Sales Bridge** Sales $18 $741 $45 Reported sales of $741M, an increase of 8% $(5) compared to the prior year $683 7% organic sales increase driven by growth in all segments Favorable currency impact of 3% and unfavorable net impact of 1% from 2Q 2025 Organic Acq
Slide 6: Industrial Precision Solutions – 2Q 2026
Industrial Precision Solutions – 2Q 2026 2Q 2026 IPS Sales Bridge* Sales $13 $350 $16 $3 Sales of $350 million, a 10% increase, including a $319 favorable currency impact of 4% and a 1% contribution from the Capstan AG acquisition Organic sales increased 5% driven by industrial coating and polym
Slide 7: Medical and Fluid Solutions – 2Q 2026
Medical and Fluid Solutions – 2Q 2026 2Q 2026 MFS Sales Bridge* Sales $16 $2 $213 Sales of $213 million, a 5% increase, inclusive of the divested sales impact of (4)% $(8) $203 Organic sales increase of 8% driven by growth in engineered fluid solutions and medical product lines EBITDA 2Q 2025 Or
Slide 8: Advanced Technology Solutions – 2Q 2026
Advanced Technology Solutions – 2Q 2026 2Q 2026 ATS Sales Bridge* Sales $14 $3 $178 Sales were a record $178 million, an increase of 10% $161 8% organic sales increase driven by ongoing strength in electronics dispense systems Favorable currency impact of 2% 2Q 2025 Organic Currency 2Q 2026 EB
Slide 9: Balance Sheet and Cash Flow
Balance Sheet and Cash Flow Balanced Capital Deployment Returning Value to Shareholders Net Debt Net Debt 2.5x Cash totaled $102 million 2.1x 1.9x 1.9x net debt leverage ratio based on trailing $2,089 12-month EBITDA, a 0.2x improvement from year end $1,888 $1,784 $900 million in capacity avai
Slide 10: Strategic Capital Allocation
Invested $10M in capital investments to fuel new capabilities and future growth Paid $46M in dividends Completed $43M in share Strategic repurchases Capital Reduced net debt by $93M, leverage ratio down 0.2x to 1.9x Allocation Closed on small, strategic acquisition in precision ag 10
Slide 11: Expanding precision ag portfolio
Expanding precision ag portfolio Acquired CapstanAG, a precision ag leader based in Topeka, Kansas for 9X adjusted EBITDA Strategic acquisition positioning for growth in North America mid-tier OEM market Differentiated nozzle-by-nozzle controls increase efficiency and reduce waste Notable sy
Slide 12: Well-Positioned to Deliver Organic Growth
Well-Positioned to Deliver Organic Growth Electronics & Medical Consumer Industrial Remaining Semiconductors Nondurable Markets LT Growth Rate: LT Growth Rate LT Growth Rate: LT Growth Rate: LT Growth Rate: MSD MSD+ LSD LSD MSD 27% of Revenue 25% of Revenue 23% of Revenue 13% of Revenue 12% of Reven
Slide 13: 3Q Fiscal 2026 Guidance
3Q Fiscal 2026 Guidance Continued stability in industrial Q3 FY2026 Revenue Guidance $760 - $790 and medical end markets $742 combined with robust momentum $662 in electronic end markets Q3 FY2026 revenue of $760 - $790 million Q3 FY2026 adjusted earnings per share in the 3Q 2024 3Q 2025 3Q 2026
Slide 14: 2026 Fiscal Full Year Guidance
2026 Fiscal Full Year Guidance Full Year Outlook Increased Again after Strong 1H Order entry strength continued during the quarter Assumes FX rates hold at current levels and with backlog up 18% YOY, excluding the impact in the second half on a YOY basis is divestiture from prior year neutral; t
Slide 15: Questions?
CNordson Questions?
Slide 16: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Net Income to EBITDA (Dollars in thousands) 16
Slide 17: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Adjusted Net Income and Earnings Per Share (Dollars in thousands) 17
Slide 18: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Operating Cash Flow to Free Cash Flow 18
Slide 19: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Operating Cash Flow to Free Cash Flow 19